• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于估算药物在生物膜中分配情况的可靠且快速的方法。

A reliable and rapid procedure to estimate drug partitioning in biomembranes.

作者信息

Custódio J B, Almeida L M, Madeira V M

机构信息

Laboratório de Bioquímica, Faculdade de Farmácia, Combra, Portugal.

出版信息

Biochem Biophys Res Commun. 1991 May 15;176(3):1079-85. doi: 10.1016/0006-291x(91)90394-m.

DOI:10.1016/0006-291x(91)90394-m
PMID:2039491
Abstract

A direct method using derivative spectrophotometry was developed for determining membrane-water molar partition coefficients (Kp) of the anticancer drugs tamoxifen (TAM) and 4-hydroxytamoxifen (OHTAM). This method explores a shift in the absorption spectra of the drugs when removed from the aqueous phase to a hydrophobic environment. Partition of TAM and OHTAM depends on membrane composition and on drug concentration, temperature and presence of cholesterol. Unlike OHTAM, partition of TAM in DMPC bilayers, liposomes of sarcoplasmic reticulum (SR) lipids and native membranes of SR and mitochondria decreases linearly with drug concentration. Additionally, the partition of these drugs is higher in SR native membranes than in liposomes of SR lipids. The partition also depends on membrane type, being higher in mitochondria than in SR membranes. Maximal partitionings in DMPC are observed at temperatures in the range of the main phase transition. Cholesterol strongly affects the incorporation of drugs and maximal inhibition was observed in DMPC bilayers.

摘要

开发了一种使用导数分光光度法的直接方法来测定抗癌药物他莫昔芬(TAM)和4-羟基他莫昔芬(OHTAM)的膜-水摩尔分配系数(Kp)。该方法探索了药物从水相转移到疏水环境时吸收光谱的变化。TAM和OHTAM的分配取决于膜组成、药物浓度、温度以及胆固醇的存在。与OHTAM不同,TAM在二肉豆蔻酰磷脂酰胆碱(DMPC)双层膜、肌浆网(SR)脂质体以及SR和线粒体的天然膜中的分配随药物浓度呈线性下降。此外,这些药物在SR天然膜中的分配高于在SR脂质体中的分配。分配还取决于膜类型,在线粒体中比在SR膜中更高。在主相变温度范围内观察到DMPC中的最大分配。胆固醇强烈影响药物的掺入,并且在DMPC双层膜中观察到最大抑制作用。

相似文献

1
A reliable and rapid procedure to estimate drug partitioning in biomembranes.一种用于估算药物在生物膜中分配情况的可靠且快速的方法。
Biochem Biophys Res Commun. 1991 May 15;176(3):1079-85. doi: 10.1016/0006-291x(91)90394-m.
2
The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranes.抗癌药物他莫昔芬的活性代谢物羟基他莫昔芬可诱导细胞膜发生结构变化。
Biochim Biophys Acta. 1993 Dec 12;1153(2):308-14. doi: 10.1016/0005-2736(93)90420-5.
3
The anticancer drug tamoxifen induces changes in the physical properties of model and native membranes.抗癌药物他莫昔芬会引起模型膜和天然膜物理性质的变化。
Biochim Biophys Acta. 1993 Aug 15;1150(2):123-9. doi: 10.1016/0005-2736(93)90080-j.
4
Comparisons of the interaction of propranolol and timolol with model and biological membrane systems.普萘洛尔和噻吗洛尔与模型及生物膜系统相互作用的比较。
Mol Pharmacol. 1983 Sep;24(2):259-69.
5
Partition of malathion in synthetic and native membranes.马拉硫磷在合成膜和天然膜中的分配
Biochim Biophys Acta. 1987 Jul 10;901(1):61-6. doi: 10.1016/0005-2736(87)90256-2.
6
Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity.他莫昔芬和羟基他莫昔芬作为脂质过氧化的膜内抑制剂。过氧自由基清除活性的证据。
Biochem Pharmacol. 1994 Jun 1;47(11):1989-98. doi: 10.1016/0006-2952(94)90073-6.
7
Partition of lindane in synthetic and native membranes.
Biochim Biophys Acta. 1985 Nov 7;820(2):165-72. doi: 10.1016/0005-2736(85)90109-9.
8
Partition of parathion in synthetic and native membranes.
Biochim Biophys Acta. 1984 Nov 21;778(1):49-56. doi: 10.1016/0005-2736(84)90446-2.
9
Modulation of sarcoplasmic reticulum Ca2+-pump activity by membrane fluidity.膜流动性对肌浆网Ca2+泵活性的调节作用。
Biochemistry. 1984 Sep 25;23(20):4714-20. doi: 10.1021/bi00315a029.
10
Evidence that lipid lateral phase separation induces functionally significant structural changes in the Ca+2ATPase of the sarcoplasmic reticulum.有证据表明,脂质侧向相分离会在肌浆网的Ca+2ATP酶中诱导功能上显著的结构变化。
Biophys J. 1990 Jul;58(1):205-17. doi: 10.1016/S0006-3495(90)82366-3.

引用本文的文献

1
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.他莫昔芬治疗骨髓增生性肿瘤:一项 II 期临床试验和探索性分析。
Nat Commun. 2023 Nov 25;14(1):7725. doi: 10.1038/s41467-023-43175-5.
2
On the Mechanism of Membrane Permeabilization by Tamoxifen and 4-Hydroxytamoxifen.关于他莫昔芬和4-羟基他莫昔芬使膜通透化的机制
Membranes (Basel). 2023 Feb 28;13(3):292. doi: 10.3390/membranes13030292.
3
Regulation of Lipid Membrane Partitioning of Tamoxifen by Ionic Strength and Cholesterol.
离子强度和胆固醇对他莫昔芬在脂膜中分配的调节。
Pharm Res. 2020 Feb 10;37(3):53. doi: 10.1007/s11095-020-2771-8.
4
An Integrated Microfluidic Platform for Quantifying Drug Permeation across Biomimetic Vesicle Membranes.用于定量测定仿生囊泡膜药物渗透的集成微流控平台。
Mol Pharm. 2019 Jun 3;16(6):2494-2501. doi: 10.1021/acs.molpharmaceut.9b00086. Epub 2019 Apr 29.
5
17β-Estradiol Directly Lowers Mitochondrial Membrane Microviscosity and Improves Bioenergetic Function in Skeletal Muscle.17β-雌二醇直接降低骨骼肌线粒体膜微粘度并改善其生物能量功能。
Cell Metab. 2018 Jan 9;27(1):167-179.e7. doi: 10.1016/j.cmet.2017.10.003. Epub 2017 Nov 2.
6
Interactions of the anticancer drug tamoxifen with lipid membranes.抗癌药物他莫昔芬与脂质膜的相互作用。
Biophys J. 2015 May 19;108(10):2492-2501. doi: 10.1016/j.bpj.2015.04.010.
7
Crystallization around solid-like nanosized docks can explain the specificity, diversity, and stability of membrane microdomains.围绕类似固体的纳米码头的结晶可以解释膜微域的特异性、多样性和稳定性。
Front Plant Sci. 2014 Mar 5;5:72. doi: 10.3389/fpls.2014.00072. eCollection 2014.
8
Measuring selective estrogen receptor modulator (SERM)-membrane interactions with second harmonic generation.用二次谐波产生技术测量选择性雌激素受体调节剂(SERM)与膜的相互作用。
J Am Chem Soc. 2014 Jan 29;136(4):1409-17. doi: 10.1021/ja409250y. Epub 2014 Jan 21.
9
The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen.抗雌激素 4-羟基他莫昔芬可预防异维 A 酸诱导的肝线粒体通透性转换和生物能量功能障碍:与他莫昔芬的比较。
J Bioenerg Biomembr. 2013 Aug;45(4):383-96. doi: 10.1007/s10863-013-9517-9. Epub 2013 Jun 19.
10
Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance.不同CYP2D6表型女性中他莫昔芬及其代谢物的生理药代动力学建模为他莫昔芬质量平衡提供了新的见解。
Front Pharmacol. 2012 May 21;3:92. doi: 10.3389/fphar.2012.00092. eCollection 2012.